Adaptive Biotechnologies Corp
ADPTFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Adaptive Biotechnologies Corp Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Source: Adaptive Biotechnologies Corp — 10-K filed Feb 26, 2026
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 9 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 30, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Legato Capital Management LLC | 2026-03-31 | 152,339 | $2.11M | SEC filing |
| LAZARD ASSET MANAGEMENT LLC | 2026-03-31 | 25,098 | $348K | SEC filing |
| Robeco Institutional Asset Management B.V. | 2026-03-31 | 11,652 | $162K | SEC filing |
| PBU - The Pension Fund of Early Childhood & Youth Educators | 2026-03-31 | 378,069 | $5.25M | SEC filing |
| COMMONWEALTH EQUITY SERVICES, LLC | 2026-03-31 | 32,017 | $444K | SEC filing |
| Ameritas Investment Partners, Inc. | 2026-03-31 | 12,485 | $173K | SEC filing |
| DIMENSIONAL FUND ADVISORS LP | 2026-03-31 | 188,338 | $2.61M | SEC filing |
| Counterpoint Mutual Funds LLC | 2026-03-31 | 307,268 | $4.26M | SEC filing |
| Police & Firemen's Retirement System of New Jersey | 2026-03-31 | 41,151 | $571K | SEC filing |
| Bayesian Capital Management, LP | 2026-03-31 | 19,485 | $270K | SEC filing |
| Erste Asset Management GmbH | 2026-03-31 | 35,700 | $459K | SEC filing |
| RENAISSANCE TECHNOLOGIES LLC | 2026-03-31 | 239,800 | $3.33M | SEC filing |
| SummitTX Capital, L.P. | 2026-03-31 | 317,624 | $4.41M | SEC filing |
| Rockefeller Capital Management L.P. | 2026-03-31 | 17,263 | $240K | SEC filing |
| Parallel Advisors, LLC | 2026-03-31 | 10,078 | $140K | SEC filing |
| Persistent Asset Partners Ltd | 2026-03-31 | 6,689 | $92.8K | SEC filing |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 2026-03-31 | 35,558 | $494K | SEC filing |
| Robertson Stephens Wealth Management, LLC | 2026-03-31 | 97,218 | $1.35M | SEC filing |
| Kingdom Financial Group LLC. | 2026-03-31 | 23 | $319 | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 259,176 | $3.33M | SEC filing |
120 filers have only one report here.
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-29 | BENZENO SHARON · Chief Commercial Ofc Imm Med | Common Stock | S — Open market or private sale | −154,768 | 21.14 | SEC filing |
| 2026-06-26 | BENZENO SHARON · Chief Commercial Ofc Imm Med | Common Stock | S — Open market or private sale | −11,034 | 21.00 | SEC filing |
| 2026-06-25 | BOBULSKY SUSAN · Chief Commercial Officer, MRD | Common Stock | S — Open market or private sale | −5,000 | 20.50 | SEC filing |
| 2026-06-25 | GRIFFIN MICHELLE RENEE · Director | Common Stock | S — Open market or private sale | −52,084 | 20.18 | SEC filing |
| 2026-06-16 | ROBINS HARLAN S · Chief Scientific Officer | Common Stock | S — Open market or private sale | −6,160 | 18.01 | SEC filing |
| 2026-06-15 | ROBINS HARLAN S · Chief Scientific Officer | Common Stock | S — Open market or private sale | −100,000 | 17.37 | SEC filing |
| 2026-06-11 | BOBULSKY SUSAN · Chief Commercial Officer, MRD | Common Stock | S — Open market or private sale | −5,000 | 19.00 | SEC filing |
| 2026-06-04 | BOBULSKY SUSAN · Chief Commercial Officer, MRD | Common Stock | S — Open market or private sale | −11,000 | 18.00 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-29 | BENZENO SHARON · Chief Commercial Ofc Imm Med | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −1,837 | SEC filing |
| 2026-06-29 | BENZENO SHARON · Chief Commercial Ofc Imm Med | Common Stock | M — Exercise or conversion of derivative security | +24,944 | SEC filing |
| 2026-06-29 | BENZENO SHARON · Chief Commercial Ofc Imm Med | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −51,570 | SEC filing |
| 2026-06-29 | BENZENO SHARON · Chief Commercial Ofc Imm Med | Common Stock | M — Exercise or conversion of derivative security | +24,944 | SEC filing |
| 2026-06-29 | BENZENO SHARON · Chief Commercial Ofc Imm Med | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −24,944 | SEC filing |
| 2026-06-29 | BENZENO SHARON · Chief Commercial Ofc Imm Med | Common Stock | M — Exercise or conversion of derivative security | +1,837 | SEC filing |
| 2026-06-29 | BENZENO SHARON · Chief Commercial Ofc Imm Med | Common Stock | M — Exercise or conversion of derivative security | +51,570 | SEC filing |
| 2026-06-26 | BENZENO SHARON · Chief Commercial Ofc Imm Med | Common Stock | M — Exercise or conversion of derivative security | +11,034 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.